Get started

Zomedica

ZOMEDICA CORP STOCK Analysis Technical Analysis The Idea is to go long following the Major trend: Option 1: if 2.00 USD resistance will not be broken - Wait the end of a possible price retracement before going log (it might go down to 1.45 USD) Option 2: if 2.00 USD resistance will be broken in the next days, go long aiming to reach Target Price 1 and then 2. Fundamental Analysis The veterinary health specialist is slated to launch its patented Truforma diagnostic system on March 30. The platform is designed to produce fast and accurate results when used to detect diseases in dogs and cats. The Idea is to go long following the Major trend: Option 1: if 2.00 USD resistance will not be broken - Wait the end of a possible price retracement before going log (it might go down to 1.45 USD) Option 2: if 2.00 USD resistance will be broken in the next days, go long aiming to reach Target Price 1 and then 2. AMEX:ZOM
AMEX:ZOMLong
by Mauriello
ZOMEDICA 30% Short LETS SQUEEZE! PT $6!Zomedica Corp. is on the road back to it’s ATH. Easy Hold with a lot of Upside into the New Year Truforma will be released in April 2021!!! February Earning will include Preorders of Truforma Sales Ex CEO of Pfizer is our New CEO He Pushed Out Viagra Back in the Day Ex Vice President of IDEXX is on the Zomedica board also holding 600,000 shares at 16 Cents Board Members, Owners, Works, Banks JP Morgan, Morgan Stanley, Cambridge Are In! Has a lot upswing going into 2021 Even More LT Remember Big Guns can’t go to hard in accumulation it’s not allowed by most institutions and banks. Because it’s under $1 they like stocks that are in the $5 range but as soon as we are in the dollar range which is closer to March a lot PR will be released by their team to skyrocket this to $5+!!! $IDEXX $400+ $ZTS MERGER RUMORS $QRVO $150+ Zomedica’s Partner in Truforma Make sure your not lending your shares to shorts!!! This about all your investments!!! Check with your Broker!!! Very Important!!! $ZOM will be $1+ April 2021 it’s under 25 Cents a Share Always Do Your Own DD Guys!!! The verified Facts: TRUFORMA Commercialization announced for March 2021, domestication & R/S denied, we have forced their hand and are secure Long Term, lawsuit working towards mediation in another 2-11 months, internal launch team complete,70 pending & approved patents, 5 Assays, pending validations and FDA approvals, Qorvo Partnership, Bulk Acoustic Wave (“BAW”) technology, Projected $2.8 billion industry, believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine, latest find is new career openings for (professional services veterinarian, territory diagnostic specialist, and scientist).
BITSTAMP:BTCUSDLong
by itsJ718
Zomedica Upcoming TRUFORMA™ on March 30, 2021Protected by approximately 70 issued and pending patents, the TRUFORMA diagnostic platform uses Bulk Acoustic Wave (“BAW”) technology, developed by Qorvo (NASDAQ: QRVO), to provide a non-optical and fluorescence-free detection system for use at the point-of-care. BAW technology, also used in cell phones and in the world’s most advanced radar and communications systems, is an extremely reliable and precise technology. Zomedica expects to begin commercial sales of TRUFORMA on March 30, 2021. Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. (source: globenewswire.com) Please leave me a message if you want to test the buy and sell indicators that i am using.
AMEX:ZOMLong
by BuySellMarketMaker
12
BIG ZOM BIG DREAMStoo many peoples is coming here tlaking about tings like charts and patturns but what about the stuff that matters let me tell you a story of a little company that saids, hey lets makes the stuff for peeps to treat animal rite? eya too many companie pushing theories and research with no practicals use. they publish all this stuffs but where da cheese? where da bidness acumen? where da practic to da theori? well my frens this where tha zom is comin dey gots tha lemons and tha juice, so dont come crying to mama when ya magic charts did ya dirty. go looky looky at der product about to make lunch in 2021. with that kind of design dey be flying off tha shelves, i call all my ventrilnatina animal frens and say, yo bruhzuwala yo geetin tha zomedica stufsfs and of course they sday "AHA OH YEAH BABYCAKES HYUCK DUHAH WE GOOFY FO DAT SHIZ" if you hav been followin my smart guide u made millions off natilus and lost it all on tesla puts. now its time to take that 0 and multiply it by 10x to take home da big bux with a nice ZOM sanwich. SPECIAL NOTE: wall street bets autists will be talking about this stonk soon so buy before they do!!!!11111
AMEX:ZOMLong
by coinhoIio
5
ZOM to retest the 200ma perhaps?I think the latest days have been amazing for ZOM, Truforma is coming in Q121 and so other solutions in the pipeline, the prospects for the company are very good. This team have been working for years and deserve a better company stock valuation now with their new developed technology. For the short time, I think the stock is likely to retest the 200ma, perhaps around 12ish and consolidate, but I wouldn't get surprise if the stock shoots up to 20 cents or over.
AMEX:ZOMLong
by Allenvik
Time for a reversal?As we have seen in the last couple of months, when a divergence signal (green #1 on chart), a Tom Demark Seq signal (red #8 on chart), Stoch RSI below 20 and VIX FIX bottom indicator(green bars below the chart) appears together, there is a reversal. The price could not break 0.10 downwards and it showed high buy volumes during the first week of september. Investors are waiting for the decision for a potential Reverse Split after the proxy voting results at the Annual Shareholders meeting on September 25th. But I think a reversal will take place until the meeting to carry the share price around $0.20 before landing back at the 0.13-0.16 range.
AMEX:ZOMLong
by Kryptolinks
ZOM - Zomedica Pharmaceuticals Corp Technical AnalysisTechnical Analysis - Based on the last month price behaviour that after the Public offering the share from 0.15 went up to more than 0.2 and based on technical analysis, it seems that there is a possibility to go long. (two different target prices have been found. Fundamental News. Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering. Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of its previously announced public offering of 187,500,000 common shares (or common share equivalents) of the Company, together with short-term warrants to purchase up to 187,500,000 common shares, at a combined public offering price of $0.16 per share and accompanying warrant. Each common share (or common share equivalent) is being sold in the offering together with one two-year warrant to purchase one common share at an exercise price of $0.16 per common share. There is no public trading market for the warrants, and Zomedica does not expect a market to develop. Zomedica intends to use the net proceeds from the offering primarily for the continued development of its TRUFORMA™ diagnostic platform, including making milestone payments, as they come due, under its existing license and collaboration agreements, other general corporate and working capital purposes and may use a portion of the net proceeds to repurchase some or all of its outstanding Series 1 Preferred Shares, although no agreement has been reached with respect to the terms or conditions of any such repurchase.
AMEX:ZOMLong
by Mauriello
5